These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 21784858)

  • 1. Adiponectin ameliorates doxorubicin-induced cardiotoxicity through Akt protein-dependent mechanism.
    Maruyama S; Shibata R; Ohashi K; Ohashi T; Daida H; Walsh K; Murohara T; Ouchi N
    J Biol Chem; 2011 Sep; 286(37):32790-800. PubMed ID: 21784858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
    Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
    Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation.
    Konishi M; Haraguchi G; Ohigashi H; Ishihara T; Saito K; Nakano Y; Isobe M
    Cardiovasc Res; 2011 Feb; 89(2):309-19. PubMed ID: 20978005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin regulates SR Ca(2+) cycling following ischemia/reperfusion via sphingosine 1-phosphate-CaMKII signaling in mice.
    Yan W; Zhang F; Zhang R; Zhang X; Wang Y; Zhou F; Xia Y; Liu P; Gao C; Wang H; Zhang L; Zhou J; Gao F; Gao E; Koch WJ; Wang H; Cheng H; Qu Y; Tao L
    J Mol Cell Cardiol; 2014 Sep; 74():183-92. PubMed ID: 24852843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes.
    Yamamoto Y; Hoshino Y; Ito T; Nariai T; Mohri T; Obana M; Hayata N; Uozumi Y; Maeda M; Fujio Y; Azuma J
    Cardiovasc Res; 2008 Jul; 79(1):89-96. PubMed ID: 18346979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
    Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
    Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor attenuates doxorubicin-induced cardiac dysfunction through activating Akt signalling in rats.
    Hang P; Zhao J; Sun L; Li M; Han Y; Du Z; Li Y
    J Cell Mol Med; 2017 Apr; 21(4):685-696. PubMed ID: 28098423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acylated Ghrelin Protects the Hearts of Rats from Doxorubicin-Induced Fas/FasL Apoptosis by Stimulating SERCA2a Mediated by Activation of PKA and Akt.
    Shati AA; Dallak M
    Cardiovasc Toxicol; 2019 Dec; 19(6):529-547. PubMed ID: 31093930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
    van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
    J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.
    Durham KK; Chathely KM; Mak KC; Momen A; Thomas CT; Zhao YY; MacDonald ME; Curtis JM; Husain M; Trigatti BL
    Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H31-H44. PubMed ID: 28986362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.
    Venkatesan B; Prabhu SD; Venkatachalam K; Mummidi S; Valente AJ; Clark RA; Delafontaine P; Chandrasekar B
    Cell Signal; 2010 May; 22(5):809-20. PubMed ID: 20074638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
    Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
    J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21(Cip1.).
    Cheng Z; DiMichele LA; Rojas M; Vaziri C; Mack CP; Taylor JM
    J Mol Cell Cardiol; 2014 Feb; 67():1-11. PubMed ID: 24342076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes.
    Essick EE; Wilson RM; Pimentel DR; Shimano M; Baid S; Ouchi N; Sam F
    PLoS One; 2013; 8(7):e68697. PubMed ID: 23894332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
    Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction.
    Negoro S; Oh H; Tone E; Kunisada K; Fujio Y; Walsh K; Kishimoto T; Yamauchi-Takihara K
    Circulation; 2001 Jan; 103(4):555-61. PubMed ID: 11157722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice.
    Ikeda Y; Aihara K; Akaike M; Sato T; Ishikawa K; Ise T; Yagi S; Iwase T; Ueda Y; Yoshida S; Azuma H; Walsh K; Tamaki T; Kato S; Matsumoto T
    Mol Endocrinol; 2010 Jul; 24(7):1338-48. PubMed ID: 20501642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury.
    Means CK; Xiao CY; Li Z; Zhang T; Omens JH; Ishii I; Chun J; Brown JH
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2944-51. PubMed ID: 17293497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1qTNF-related protein-6 protects against doxorubicin-induced cardiac injury.
    Zheng WF; Zhang SY; Ma HF; Chang XW; Wang H
    J Cell Biochem; 2019 Jun; 120(6):10748-10755. PubMed ID: 30719766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.